⌘K

Login Start Free

Home/Filings/4/0001415889-22-008287

4//SEC Filing

Galle Liz 4

Accession 0001415889-22-008287

CIK 0001235912other

View on SEC.gov Company Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 8:25 PM ET

Size

5.3 KB

Accession

0001415889-22-008287

Insider Transaction Report

Form 4

Period: 2022-08-02

VP of Global Clinical Research

Transactions

Award
Stock Option (right to buy)
2022-08-02+8,000→ 8,000 total
Exercise: $9.01Exp: 2032-08-01→ Common Stock (8,000 underlying)

Footnotes (1)

[F1]Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter.

Documents

1 file

4
form4-08042022_050857.xmlPrimary

Issuer

CVRx, Inc.

CIK 0001235912

Entity typeother

Related Parties

1

filerCIK 0001869353

Filing Metadata

Form type: 4
Filed: Aug 3, 8:00 PM ET
Accepted: Aug 4, 8:25 PM ET
Size: 5.3 KB

View on SEC.gov